Inhibition by Liposomal Cholesterol of Streptococcus Pneumoniae Induced Lung Epithelial Cell Damage

References

• Boulnois G.J. Pneumococcal proteins and the pathogenesis of disease caused by Streptococcus pneumoniae. J. Gen. Microb. 1992; 138: 249–259
   PubMedGoogle Scholar
• Tuomanen E.I., Austrian R., Masure H.R. Pathogenesis of pneumococcal infections. New Engl. J. Med. 1995; 332: 1280–1284
   PubMed Web of Science ®Google Scholar
• Musher D.M. Infections caused by Streptococcus pneumoniae: clinical spectrum, pathogenesis, immunity and treatment. Clin. Infect. Dis. 1992; 14: 801–809
   PubMed Web of Science ®Google Scholar
• Alonso DeVelasco E., Verheul A.F., Verhoef J., Snippe H. Streptococcus pneumoniae : virulence factors, pathogenesis, and vaccines. Microbiol. Rev. 1995; 59: 591–603
   PubMedGoogle Scholar
• Rubins J.B., Paddock A.H., Charboneau D., Berry A.M., Paton J.C., Janoff E.N. Pneumolysin in pneumoccocal adherence and colonization. Microb. Pa-thog. 1998; 25: 337–342
   PubMed Web of Science ®Google Scholar
• Canvin J.R., Marvin A.P., Sivakumaran M., Paton J.C., Boulnois G.J., Andrew P.W., Mitchell T.J. The role of pneumolysin and autolysin in the pathology of pneumonia and septicimia in mice infected with a type 2 pneumococcus. J. Infect. Dis. 1995; 172: 119–123
   PubMedGoogle Scholar
• Paton J.C. The contribution of pneumolysin to the pathogenicity of Streptococcus pneumoniae. Trends. Microbiol. 1996; 4: 103–106
   PubMed Web of Science ®Google Scholar
• Steinfort C., Wilson R., Mitchell T.J., Feldman C., Rutman A., Todd H., Sykes D., Walker J., Saunders K., Andrew P.W. Effect of Streptococcus pneumoniae on human respiratory epilthelium in vitro. Infect. Imunn. 1989; 57: 2006–2013
   PubMed Web of Science ®Google Scholar
• Feldman C., Mitchell T.J., Andrew P.W., Boulnois G.J., Read R.C., Todd H.C., Cole P.J., Wilson R. The effect of Streptococcus pneumoniae on human respiratory epithelium in vitro. Microb. Pathog. 1990; 9: 275–84
   PubMedGoogle Scholar
• Rubins J.B., Duane P.G., Charboneau D., Janoff E.N. Toxicity of pneumolysin to pulmonary endothelial cells in vitro. Infect. Immun. 1992; 60: 1740–1746
   PubMedGoogle Scholar
• Rayner C.F.J., Jackson A.D., Putman A., Dewar A., Mitchell T.J., Andrew P.W., Cole P.J., Wilson R. Interaction of pneumolysin sufficient and deficient isogenic variants of Streptococcus pneumoniae with human respiratory mucosa. Infect. Immun. 1995; 63: 442–447
   PubMed Web of Science ®Google Scholar
• Rubins J.B., Duane P.G., Clawson D., Charboneau D., Young J., Nie-Woehner D.E. Toxicity of pneumolysin to pulmonary epithelial cells. Infect. Immun. 1993; 61: 1352–1358
   PubMed Web of Science ®Google Scholar
• Ferrante J.B., Rowan-Kelly B., Paton J.C. Inhibition of in vitro human lymphocytes response by the pneumococcal toxin pneumolysin. Infect. Immun. 1984; 46: 585–589
   PubMedGoogle Scholar
• Rossjohn J., Gilbert R.J.C., Crane D., Morgan P.J., Mitchell T.J., Rowe A.J., Andrew P.W., Paton J.C., Tweten R.K., Parker M.W. The molecular mechanism of pneumolysis a virulence factor for Streptococcus pneumoniae. J. Mol. Biol. 1998; 284: 449–461, References cited therein
   PubMed Web of Science ®Google Scholar
• Morgan P.J., Hyman S.C., Rowe A.J., Mitchell T.J., Andrew P.W., Saibil H. Subunit organization and symmetry of pore-forming. Oligomeric pneumolysis FEBS 1995; 37: 77–80
   Google Scholar
• Morgan P.J., Varley P.G., Rowe A.J., Andrew P.W., Mitchell T.J. Characterization of the solution properties and conformation of pneumolysis the membrane-damaging toxin of Streptococcus pneumoniae. Biochem J 1993; 296(Pt3)671–674, References cited therein
   PubMedGoogle Scholar
• Tweten R.K. Pore forming toxins of the gram positive bacteria. Virulence Mechanisms of Bacterial Pathogens, J.A. Rothe, C.A. Bolin, K.A. Brogden, C. Minon, M.J. Wannemuehler. American Society for Microbiology, Washington, DC 1995; 207–230
   Google Scholar
• Bortoleto R.K., de Oliveira A.H.C., Ruller R., Ami R.K., Ward R.J. Tertiary structural changes in the a-hemolysin from Streptococcus aureus on association with liposomes membranes. Archiv. Biochem. Biophys. 1998; 351: 47–52
   PubMed Web of Science ®Google Scholar
• Ohno-Iwashita Y., Iwamoto M., Ando S., Iwashita S. Effect of lipidic factors on membrane cholesterol topology- mode of binding of 6-toxin to cholesterol in liposomes. Biochim. Biophys. Acta 1992; 1109: 81–90
   PubMedGoogle Scholar
• Bernheimer A.W. Interactions between membranes and cytolytic bacterial toxins, Biochim. Biophys. Acta 1974; 344: 27–50
   Google Scholar
• Johnson M.K., Geoffroy C., Alouf J.E. Binding of cholesterol by sulfhy-dryl-activated cytolysins. Infect. Immun. 1980; 27: 97–101
   PubMed Web of Science ®Google Scholar
• Alouf J.E., Geoffroy C., Pattus F., Verger R. Surface properties of bacterial sulfhydyl-activated cytolytic toxins. Interaction with monomolecular films of phosphatidylcholine and various sterols. Eur. J Biochem. 1984; 141: 205–210
   Google Scholar
• Gaudreault R.C., Bellemare B., Lacroix J. Erythrocyte membrane-bound danorubicin as a delivery system in anticancer treatment. Anticancer Res. 1989; 9: 1201–1206
   PubMed Web of Science ®Google Scholar
• Marsh D. Handbook of lipid bilayers. CRC press, Boca Raton, Fl 1990; 136
   Google Scholar
• Bérubé L.R., Schur M.K., Latta R.K., Hirama T, McKenzie C.R., Jarrell H.C. Phosphatidyl choline-mediated inhibition of Streptococcus pneumoniae adherence to type II pneumocytes in vitro. Microb. Pathog. 1998; 26: 65–75
   Google Scholar
• Almeida P.F.F., Vaz W.L.C., Thompson T.E. Lateral diffusion in the liquid phases of dimyristoylphasphatidylcholine/cholesterol lipid bilayers: a free volume analysis. Biochemistry 1992; 31: 6739–6747
   PubMed Web of Science ®Google Scholar
• Vist M.R., Davis J.H. Phase equilibria of cholesterol/dipalmitoylphospha-tidylcholine mixtures: 2H nuclear magnetic resonance and differential scanning calo-rimetry. Biochenistry 1990; 29: 451–464
   PubMed Web of Science ®Google Scholar
• McMullen T.P., McElhaney R.N. Differential scanning calorimetric studies of the interaction of cholesterol with disteroyl and dielaidoyl mlecular species of phsophatidylcholine, phsophatidylethanolamine and phsophatidylserine. Biochemistry 1997; 36: 4979–86
   PubMed Web of Science ®Google Scholar
• Tuomanen E., Hengstler B., Rich R., Bray M.A., Zak O., Tomasz A. Nonsteroidal anti-inflamatory agents in the therapy for experimental pneumococcal meningitis. J. Infect. Dis. 1987; 155: 985–990
   PubMed Web of Science ®Google Scholar